Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Afghanistan-Pakistan peace talks collapse, ceasefire continues, Taliban says
UPS, FedEx ground MD-11 fleets after deadly Louisville crash
US warns it could force 20% flight cuts if shutdown continues
Philippines warns of deadly storm surges as typhoon Fung-wong intensifies
Technical glitch with air traffic system at Delhi airport resolved
